US Specialty Pharmaceutical Market Reviewed in Koncept Analytics Report Recently Published at

16 Apr 2015 • by Natalie Aster

LONDON - Presently, specialty drugs form one of the swiftest growing segments of the global pharmaceutical market.

In the USA, some of main factors driving growth of the local market include: increased life expectancy, ageing of the local population, improving economic conditions, growing medicare enrollments etc. The number of companies willing to participate in this lucrative marketplace is currently on the rise. In the meantime, entrenched market players launch new novel products and participate in an increased number of M&A activities.

However, issues related to regulatory framework, intensifying pricing pressure and a lack of access to specialty pharmacy products restrain growth of this market.

The US market is dominated by such companies as Amgen Inc., Pfizer Inc., Johnson & Johnson, and more.

Insightful research report “The US Specialty Pharmaceutical Market Report: 2015 Edition” worked out by Koncept Analytics provides a comprehensive guide to the US specialty pharmaceutical market. The study offers an in-depth overview of the market. It uncovers market value and sales by dispensing channels. The report investigates key trends and developments of the market. It explores growth drivers and challenges. The research study looks at the competitive landscape and contains detailed profiles of key players. The report also examines top players’ business strategies and discusses their key financials.

Report Details:

The US Specialty Pharmaceutical Market Report: 2015 Edition
Published: March, 2015
Pages: 67
Price: US$ 800.00

More cutting-edge research studies by the publisher can be found at Koncept Analytics page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970